Tobacco Industry Sales Continue Decline
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 day ago
0mins
Should l Buy MO?
Source: Fool
- Sales Volume Decline: According to Barclays, traditional cigarette sales volumes declined year-over-year by 4.3% to 5.5%, with a 5.1% drop in 2026 compared to 2025, although this was better than the expected 7.3% decline, indicating market resilience.
- Altria's Steady Performance: Altria Group's traditional cigarette volumes fell by 4.7%, which is significantly better than British American Tobacco's 9.3% drop and Imperial Brands' 9% decline, suggesting Altria is faring better than its competitors.
- New Product Growth: While traditional tobacco sales are declining, nicotine pouch sales surged by 22%, indicating market potential for certain next-generation products, although e-cigarette sales fell sharply by 17% year-over-year.
- Dividend Appeal: With a market cap of $110 billion and a dividend yield of 6.36%, Altria remains an attractive income stock for dividend-seeking investors, even as it distances itself from the shrinking traditional market.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MO?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MO
Wall Street analysts forecast MO stock price to fall
8 Analyst Rating
4 Buy
3 Hold
1 Sell
Moderate Buy
Current: 68.200
Low
57.00
Averages
65.00
High
72.00
Current: 68.200
Low
57.00
Averages
65.00
High
72.00
About MO
Altria Group, Inc. operates a portfolio of tobacco products for United States tobacco consumers aged 21+. Its segments include smokeable products and oral tobacco products. The smokeable products segment consists of combustible cigarettes and machine-made large cigars. The oral tobacco products segment includes moist smokeless tobacco (MST) products and oral nicotine pouches. Its wholly owned subsidiaries include manufacturers of both combustible and smoke-free products. In combustibles, it owns Philip Morris USA Inc. (PM USA), and John Middleton Co. (Middleton), which are cigarette manufacturers. Its smoke-free portfolio includes ownership of U.S. Smokeless Tobacco Company LLC (USSTC), a global MST manufacturer, Helix Innovations LLC (Helix), a manufacturer of oral nicotine pouches, and NJOY, LLC (NJOY), an e-vapor manufacturer with a commercialized product portfolio. The brand portfolios of its operating companies include Marlboro, Black & Mild, Copenhagen, Skoal, on! and NJOY.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Earnings Forecast: Altria is expected to report Q1 EPS of $1.25, reflecting a 1.6% increase, with revenue anticipated to rise 1.3% to $4.58 billion, indicating stable performance amid economic uncertainty.
- Market Performance: Over the past two years, Altria has beaten revenue and EPS estimates 63% of the time, although its recent Q4 results showed profits slightly below expectations and a 2.1% sales decline, primarily due to lower net revenues in smokeable products.
- Competitive Analysis: Rival Philip Morris International reported a 2.7% organic revenue increase in Q1, but total shipment volume fell by 1.9%, highlighting challenges faced by the industry, prompting investors to monitor Altria's shipment volumes closely.
- Future Outlook: Analysts project a 2.0% Compound Annual Growth Rate for Altria over the next five years, despite concerns over the secular decline in traditional cigarette shipments and uncertainties with new products, yet current valuation metrics and growth catalysts suggest a favorable investment outlook.
See More
- Earnings Beat: Altria reported a non-GAAP EPS of $1.32, exceeding expectations by $0.07, with revenue of $4.76 billion beating estimates by $180 million, indicating some resilience in profitability despite ongoing challenges, yet market confidence in future growth is waning.
- Market Share Decline: Despite the earnings beat, Altria's declining market share remains a significant concern, potentially leading to further revenue and profit declines, which could adversely affect shareholder returns and overall company valuation.
- Dividend Sustainability Risk: As a Dividend King, Altria's dividend policy is threatened by declining market share and uncertain profitability, raising investor concerns about its ability to maintain future dividend payments, which may pressure the stock price.
- Changing Industry Landscape: With tightening regulations and shifting consumer preferences, Altria faces competitive challenges in the tobacco industry, necessitating effective strategies to adapt to the evolving market environment to ensure long-term survival and growth.
See More
- Earnings Beat: Altria reported a non-GAAP EPS of $1.32, exceeding expectations by $0.07, with revenue of $4.76 billion surpassing forecasts by $180 million, indicating some resilience in profitability despite challenges.
- Market Share Decline: Despite the earnings beat, Altria's declining market share remains a significant hurdle for future growth, potentially impacting its long-term strategy and investor confidence.
- Dividend Policy Risks: As a Dividend King, Altria faces pressure to maintain its high dividend payouts, raising concerns about its future ability to sustain these payments, which may lead investors to reassess its value.
- Wall Street Sentiment Shift: With changing perceptions on Wall Street, analysts are adopting a more cautious stance on Altria's future prospects, which could affect its stock performance and overall market confidence.
See More
- Performance Growth: In Q1 2026, Altria Group reported net revenues of $5.428 billion, a 3.2% increase year-over-year, primarily driven by strong performance in the smokeable products segment, indicating the company's resilience in a competitive market.
- Earnings Per Share Increase: Adjusted diluted EPS rose by 7.3% to $1.32, reflecting effective management of operating companies income (OCI) and share repurchases, which enhanced shareholder returns significantly.
- Shareholder Return Program: In Q1 2026, Altria repurchased 4.5 million shares at an average price of $62.33 per share, totaling $280 million, demonstrating the company's confidence in future cash flows and commitment to shareholders.
- Full-Year Guidance: The company reaffirmed its expectation for 2026 adjusted diluted EPS to be in the range of $5.56 to $5.72, representing a growth rate of 2.5% to 5.5%, indicating cautious optimism about future market conditions, especially amid slowing growth in the e-vapor sector.
See More
- Profit Beat: Altria reported an adjusted profit per share of $1.32 for Q1, exceeding Wall Street's estimate of $1.25, indicating effective strategies in price increases and cost controls.
- Volume Decline Mitigation: Despite declining cigarette volumes, Altria successfully offset pressures from intensified competition by raising prices and implementing cost control measures, ensuring stable profitability.
- Intensified Market Competition: Facing increasing competition in nicotine products, Altria's performance highlights its adaptability and strategic responses in the market, potentially laying the groundwork for future market share battles.
- Financial Resilience: The earnings report demonstrates Altria's ability to maintain profitability in adversity, reflecting strong financial management and market responsiveness, which provides confidence to investors.
See More
- Earnings Beat: Altria reported a Q1 non-GAAP EPS of $1.32, surpassing expectations by $0.07, indicating robust profitability that may bolster investor confidence.
- Revenue Growth: The company achieved $4.76 billion in revenue for Q1, a 5.3% year-over-year increase that exceeded expectations by $180 million, primarily driven by growth in the smokeable products segment, reflecting strong market demand.
- Net Revenue Increase: Net revenues rose 3.2% to $5.4 billion, showcasing the company's sustained competitiveness in the tobacco industry, which could provide funding for future investments and expansions.
- Future Guidance: Altria reaffirmed its expectation for 2026 adjusted diluted EPS to range between $5.56 and $5.72, representing a growth of 2.5% to 5.5% from a base of $5.42 in 2025, demonstrating confidence in future growth that may attract long-term investors.
See More








